A major impediment to universal access to medication is the high cost of patented drugs, which are often specifically required by patients for survival. In an attempt to make such drugs more widely available to patients, one drug company is planning to offer patients a free one-month drug supply for every $1,000 they spend on patented drugs.
Which of the following, if true, most threatens the plan's prospects for success?
A. Many patented drugs are not designed to be used for more than two weeks. B. The drug company offering free one-month supplies will increase their prices so that the effective cost per dose remains the same. C. Most patients who depend on patented drugs for survival possess insurance coverage that pays most of the cost of the drugs they require. D. Whenever possible, physicians prescribe drugs that are available in generic alternatives that are not patented. E. Patients who suffer from the most severe ailments often require multiple drugs patented by different companies as part of their daily regimen.
Correct Answer: (B)
----- Why is C not a right answer? The explanation was only that it makes the plan irrelevant, which I think hugely threatens the plan. More so than the discount not being as good as it sounds.
The question states that "a major impediment to universal access is the high cost of patented drugs." (C) simply contradicts this premise by saying affordability is not a problem. But we were not asked to find the answer choice that contradicts the premise, we were asked which answer choice would threaten the success of the company's plan. We must accept the premise that affordability is the problem, then find the answer choice that threatens the plan to make medication more affordable. The only answer choice that directly threatens the plan's goal of increasing availability by lowering prices is (B), because it would mean prices were not actually lowered at all.
Users browsing this forum: No registered users and 2 guests
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot post attachments in this forum
GMAT(TM) and GMAT CAT (TM) are registered trademarks of the Graduate Management Admission Council(TM). The Graduate Management Admission Council(TM) does not endorse, nor is affiliated in any way with the owner or any content of this site.